US6605712B1
(en)
*
|
1990-12-20 |
2003-08-12 |
Arch Development Corporation |
Gene transcription and ionizing radiation: methods and compositions
|
US5610042A
(en)
*
|
1991-10-07 |
1997-03-11 |
Ciba-Geigy Corporation |
Methods for stable transformation of wheat
|
US7285416B2
(en)
|
2000-01-24 |
2007-10-23 |
Gendaq Limited |
Regulated gene expression in plants
|
US7262055B2
(en)
|
1998-08-25 |
2007-08-28 |
Gendaq Limited |
Regulated gene expression in plants
|
US5631152A
(en)
*
|
1994-10-26 |
1997-05-20 |
Monsanto Company |
Rapid and efficient regeneration of transgenic plants
|
CZ86798A3
(cs)
|
1996-06-21 |
1999-03-17 |
Monsanto Company |
Fertilní transgenní rostlina pšenice, způsob její přípravy, buňky a semena této rostliny
|
US5773269A
(en)
*
|
1996-07-26 |
1998-06-30 |
Regents Of The University Of Minnesota |
Fertile transgenic oat plants
|
US6002068A
(en)
*
|
1996-12-19 |
1999-12-14 |
Novartis Finance Corporation |
Methods for conferring insect resistance to a monocot using a perioxidase coding sequence
|
US6872871B2
(en)
*
|
1998-02-02 |
2005-03-29 |
Odyssey Thera Inc. |
Mapping molecular interactions in plants with protein fragments complementation assays
|
US7102056B1
(en)
|
1997-04-29 |
2006-09-05 |
The Regents Of The University Of California |
Compositions and methods for plant transformation and regeneration
|
US6235529B1
(en)
|
1997-04-29 |
2001-05-22 |
The Regents Of The University Of California |
Compositions and methods for plant transformation and regeneration
|
MX257801B
(en)
|
1997-06-02 |
2008-06-10 |
Syngenta Participations Ag |
Plant transformation methods
|
US6486384B1
(en)
|
1997-09-24 |
2002-11-26 |
The Regents Of The University Of California |
Methods and compositions for transformation of cereals using cultured shoot meristematic tissue
|
ATE346944T1
(de)
|
1997-09-30 |
2006-12-15 |
Univ California |
Herstellung von proteinen in pflanzensamen
|
US6060315A
(en)
*
|
1997-12-01 |
2000-05-09 |
Lockheed Martin Energy Research Corporation |
Method for facilitating the introduction of material into cells
|
US6153811A
(en)
|
1997-12-22 |
2000-11-28 |
Dekalb Genetics Corporation |
Method for reduction of transgene copy number
|
CA2319110C
(en)
|
1998-02-20 |
2011-01-04 |
Zeneca Limited |
Hybrid seed production
|
US5973227A
(en)
*
|
1998-05-06 |
1999-10-26 |
University Of Saskatchewan |
Flax transformation
|
US20050086718A1
(en)
|
1999-03-23 |
2005-04-21 |
Mendel Biotechnology, Inc. |
Plant transcriptional regulators of abiotic stress
|
US7897843B2
(en)
|
1999-03-23 |
2011-03-01 |
Mendel Biotechnology, Inc. |
Transcriptional regulation of plant biomass and abiotic stress tolerance
|
AU782918B2
(en)
|
1999-11-10 |
2005-09-08 |
University Of Washington |
Compositions and methods for modulation of plant cell division
|
ATE531804T1
(de)
|
1999-11-17 |
2011-11-15 |
Mendel Biotechnology Inc |
Gene im zusammenhang mit der biochemie von pflanzen
|
EP1950306A1
(en)
|
1999-11-17 |
2008-07-30 |
Mendel Biotechnology, Inc. |
Environmental stress tolerance genes
|
US6812028B1
(en)
*
|
1999-12-10 |
2004-11-02 |
University Of Guelph |
Embryogenesis and plant regeneration from microspores
|
US6580019B1
(en)
|
2000-03-09 |
2003-06-17 |
Dekalb Genetics Corporation |
Non-reciprocal recombination-mediated transgene deletion in transgenic plants
|
US6750379B2
(en)
|
2000-03-09 |
2004-06-15 |
Dekalb Genetics Corporation |
Homologous recombination-mediated transgene alterations in plants
|
US6806399B1
(en)
*
|
2000-04-19 |
2004-10-19 |
Carmel-Haifa University Economic Corporation Ltd. |
Pollen-mediated method for transformation of maize, tomato or melon
|
US7468475B2
(en)
|
2000-06-16 |
2008-12-23 |
Schmuelling Thomas |
Method for modifying plant morphology, biochemistry and physiology
|
US6995016B2
(en)
|
2000-08-17 |
2006-02-07 |
Her Majesty The Queen In Right Of Canada, As Represented By The Minister Of Agriculture And Agri-Food |
Process for inducing direct somatic embryogenesis in immature scutella cells of pooideae, and rapidly regenerating fertile plants
|
EP2410060A1
(en)
|
2000-08-22 |
2012-01-25 |
Mendel Biotechnology, Inc. |
Genes for modifying plant traits IV
|
FR2815969B1
(fr)
|
2000-10-30 |
2004-12-10 |
Aventis Cropscience Sa |
Plantes tolerantes aux herbicides par contournement de voie metabolique
|
CN1541059A
(zh)
|
2001-03-06 |
2004-10-27 |
�Ϻ���ͨ��ѧ |
具有动物型糖链加成功能的植物细胞
|
US7326549B2
(en)
*
|
2001-03-19 |
2008-02-05 |
Cargill, Incorporated |
Myo-inositol oxygenases
|
US8034791B2
(en)
|
2001-04-06 |
2011-10-11 |
The University Of Chicago |
Activation of Egr-1 promoter by DNA damaging chemotherapeutics
|
CA2442971C
(en)
*
|
2001-04-06 |
2011-06-07 |
University Of Chicago |
Chemotherapeutic induction of egr-1 promoter activity
|
US20040242523A1
(en)
*
|
2003-03-06 |
2004-12-02 |
Ana-Farber Cancer Institue And The Univiersity Of Chicago |
Chemo-inducible cancer gene therapy
|
CA2448097A1
(en)
|
2001-05-22 |
2002-11-28 |
University Of Chicago |
N4 virion single-stranded dna dependent rna polymerase
|
MXPA03010967A
(es)
|
2001-05-30 |
2004-10-28 |
Chromos Molecular Systems Inc |
Cromosomas artificiales de plantas, usos de los mismos y metodos para preparar cromosomas artificiales de plantas.
|
WO2003038112A2
(en)
|
2001-10-26 |
2003-05-08 |
Baylor College Of Medicine |
A composition and method to alter lean body mass and bone properties in a subject
|
MY142457A
(en)
*
|
2001-12-11 |
2010-11-30 |
Advisys Inc |
Plasmid mediated supplementation for treating chronically ill subjects
|
US20060009409A1
(en)
*
|
2002-02-01 |
2006-01-12 |
Woolf Tod M |
Double-stranded oligonucleotides
|
EP1572902B1
(en)
*
|
2002-02-01 |
2014-06-11 |
Life Technologies Corporation |
HIGH POTENCY siRNAS FOR REDUCING THE EXPRESSION OF TARGET GENES
|
ATE443133T1
(de)
*
|
2002-02-01 |
2009-10-15 |
Life Technologies Corp |
Oligonukleotidzusammensetzungen mit verbesserter effizienz
|
CA2883729C
(en)
|
2002-05-22 |
2017-03-07 |
Virginia M. Ursin |
Fatty acid desaturases from fungi
|
US20040248094A1
(en)
*
|
2002-06-12 |
2004-12-09 |
Ford Lance P. |
Methods and compositions relating to labeled RNA molecules that reduce gene expression
|
US7667099B2
(en)
|
2002-06-20 |
2010-02-23 |
Board Of Trustees Of Michigan State University |
Plastid division and related genes and proteins, and methods of use
|
DK1636561T3
(da)
|
2002-07-15 |
2011-05-16 |
Univ Texas |
Kombinatorisk proteinbiblioteksscreening ved hjælp af periplasmatisk ekspression
|
GB0217033D0
(en)
|
2002-07-23 |
2002-08-28 |
Delta Biotechnology Ltd |
Gene and polypeptide sequences
|
US20040029275A1
(en)
*
|
2002-08-10 |
2004-02-12 |
David Brown |
Methods and compositions for reducing target gene expression using cocktails of siRNAs or constructs expressing siRNAs
|
EP2269618A1
(en)
|
2002-08-12 |
2011-01-05 |
Jennerex Biotherapeutics ULC |
An oncolytic vaccinia virus for use in combination with a chemotherapy for treating cancer.
|
WO2004022707A2
(en)
*
|
2002-09-03 |
2004-03-18 |
The Regents Of The University Of California |
Method and compositions for transformation and regeneration of maize
|
DK1546336T3
(da)
|
2002-09-18 |
2012-04-10 |
Mendel Biotechnology Inc |
Polynukleotider og polypeptider i planter.
|
ES2543084T3
(es)
|
2003-02-18 |
2015-08-14 |
Baylor College Of Medicine |
Activación inducida en células dendríticas
|
TW200424214A
(en)
*
|
2003-04-21 |
2004-11-16 |
Advisys Inc |
Plasmid mediated GHRH supplementation for renal failures
|
US7655833B2
(en)
|
2003-05-29 |
2010-02-02 |
Brookhaven Science Associates, Llc |
ADS genes for reducing saturated fatty acid levels in seed oils
|
EP1649022B1
(en)
|
2003-06-30 |
2011-07-27 |
Commonwealth Scientific And Industrial Research Organisation |
Wheat with altered branching enzyme activity and starch and starch containing products derived thereform
|
EP1788861B1
(en)
|
2004-08-24 |
2017-04-12 |
Monsanto Technology, LLC |
Adenylate translocator protein gene non-coding regulatory elements for use in plants
|
JP2008517604A
(ja)
|
2004-10-21 |
2008-05-29 |
ヴェンガンザ インコーポレイテッド |
植物の害虫および病原体に対する耐性を付与するための方法および物質
|
ES2503743T3
(es)
|
2004-11-12 |
2014-10-07 |
Asuragen, Inc. |
Procedimientos y composiciones que implican miARN y moléculas inhibidoras de miARN
|
CN100362104C
(zh)
|
2004-12-21 |
2008-01-16 |
华中农业大学 |
利用水稻转录因子基因OsNACx提高植物抗旱耐盐能力
|
AR053269A1
(es)
|
2005-05-16 |
2007-04-25 |
Monsanto Technology Llc |
Plantas y semillas de maiz con mejoramiento de asparagina y proteina
|
CA2608717A1
(en)
|
2005-05-18 |
2006-11-23 |
The Board Of Trustees Operating Michigan State University |
Resistance to soybean aphid in early maturing soybean germplasm
|
RU2421462C2
(ru)
|
2005-07-29 |
2011-06-20 |
Таргитид Гроус, Инк. |
Защитное действие доминантно-негативного мутантного белка krp от ингибирования активного комплекса циклин-cdk krp дикого типа
|
US20070059833A1
(en)
*
|
2005-09-07 |
2007-03-15 |
Maxcyte, Inc. |
Use of Nucleases to Improve Viability and Enhance Transgene Expression in Transfected Cells
|
US8980246B2
(en)
|
2005-09-07 |
2015-03-17 |
Sillajen Biotherapeutics, Inc. |
Oncolytic vaccinia virus cancer therapy
|
CN101351213B
(zh)
*
|
2005-09-07 |
2013-10-02 |
詹纳里克斯公司 |
使用表达gm-csf的痘病毒系统性治疗转移性癌和/或全身散布性癌
|
JP2009519719A
(ja)
|
2005-12-15 |
2009-05-21 |
ターゲット・グロース・インコーポレーテッド |
初期胚発生における発生及び/又は発生関連遺伝子のトランスジェニック過剰発現を通して増大された種子サイズ及び種子数
|
US7663020B2
(en)
*
|
2006-01-11 |
2010-02-16 |
Agrinomics Llc |
Generation of plants with altered oil content
|
EP1998800A2
(en)
|
2006-01-18 |
2008-12-10 |
University Of Chicago |
Compositions and methods related to staphylococcal bacterium proteins
|
US7868228B2
(en)
|
2006-01-31 |
2011-01-11 |
Monsanto Technology Llc |
Phosphopantetheinyl transferases from bacteria
|
US7820883B2
(en)
*
|
2006-03-15 |
2010-10-26 |
Dow Agrosciences Llc |
Resistance to auxinic herbicides
|
ATE485713T1
(de)
|
2006-03-31 |
2010-11-15 |
Reliance Life Sciences Pvt Ltd |
Direkte regeneration von jungpflanzen der spezies jathropha curcas
|
US7977535B2
(en)
|
2006-07-12 |
2011-07-12 |
Board Of Trustees Of Michigan State University |
DNA encoding ring zinc-finger protein and the use of the DNA in vectors and bacteria and in plants
|
US20100055113A1
(en)
|
2006-07-27 |
2010-03-04 |
The University Of Maryland, Baltimore |
Cellular receptor for antiproliferative factor
|
CA2663034C
(en)
|
2006-09-15 |
2016-05-03 |
Ottawa Health Research Institute |
Oncolytic rhabdovirus
|
CA2667396C
(en)
|
2006-09-25 |
2017-03-28 |
Freie Universitaet Berlin |
Transcriptional repressors of cytokinin signaling and their use
|
CA2666667C
(en)
*
|
2006-10-19 |
2023-06-20 |
Baylor College Of Medicine |
Generating an immune response by inducing cd40 and pattern recognition receptors
|
EP2522735A3
(en)
|
2006-10-20 |
2013-02-13 |
Arizona Board Of Regents For And On Behalf Arizona State University |
Modified cyanobacteria
|
WO2008079545A2
(en)
*
|
2006-11-15 |
2008-07-03 |
Agrigenetics, Inc. |
Generation of plants with altered protein, fiber, or oil content
|
WO2008061153A2
(en)
|
2006-11-15 |
2008-05-22 |
Agrigenetics, Inc. |
Generation of plants with altered protein, fiber, or oil content
|
US8030541B2
(en)
*
|
2006-11-15 |
2011-10-04 |
Dow Agrosciences Llc |
Generation of plants with altered protein, fiber, or oil content
|
CA2988382A1
(en)
*
|
2006-11-15 |
2008-05-22 |
Agrigenetics, Inc. |
Generation of plants with altered protein, fiber, or oil content
|
US8034993B2
(en)
*
|
2006-11-15 |
2011-10-11 |
Dow Agrosciences Llc |
Generation of plants with altered protein, fiber, or oil content
|
EP2102239B1
(en)
|
2006-11-30 |
2012-04-25 |
Research Development Foundation |
Improved immunoglobulin libraries
|
US7851672B2
(en)
*
|
2006-12-15 |
2010-12-14 |
Agrinomics Llc |
Generation of plants with altered oil, protein, or fiber content
|
MX2009006465A
(es)
*
|
2006-12-15 |
2009-08-21 |
Agrinomics Llc |
Generacion de plantas con contenido de aceite, proteina o fibra alterado.
|
CA2965042A1
(en)
*
|
2006-12-15 |
2008-06-26 |
Agrigenetics, Inc. |
Generation of plants with altered oil, protein, or fiber content
|
EP2115150A4
(en)
*
|
2006-12-15 |
2010-06-02 |
Agrinomics Llc |
GENERATION OF PLANTS WITH CHANGED OIL, PROTEIN OR FIBER CONTENT
|
CN101600342A
(zh)
*
|
2006-12-15 |
2009-12-09 |
农业经济有限责任公司 |
具有改变的油、蛋白或纤维含量的植物的生产
|
KR20080084528A
(ko)
|
2007-03-15 |
2008-09-19 |
제네렉스 바이오테라퓨틱스 인크. |
종양살상형 백시니아 바이러스 암 치료
|
CA2685675C
(en)
|
2007-05-01 |
2016-02-16 |
Research Development Foundation |
Immunoglobulin fc libraries
|
CN101715291A
(zh)
*
|
2007-06-18 |
2010-05-26 |
农业经济有限责任公司 |
具有改变的油、蛋白或纤维含量的植物的生产
|
KR20100072228A
(ko)
|
2007-08-31 |
2010-06-30 |
유니버시티 오브 시카고 |
스타필로코커스 폐 질환 및 상태에 대한 면역화와 관련된 방법 및 조성물
|
EP2245049B1
(en)
|
2008-01-10 |
2015-05-20 |
Research Development Foundation |
Vaccines and diagnostics for the ehrlichioses
|
ES2617598T3
(es)
|
2008-01-25 |
2017-06-19 |
Multivir Inc. |
Biomarcadores de P53
|
EP3447128A1
(en)
|
2008-06-04 |
2019-02-27 |
FUJIFILM Cellular Dynamics, Inc. |
Methods for the production of ips cells using non-viral approach
|
CN102171348A
(zh)
|
2008-08-12 |
2011-08-31 |
细胞动力国际有限公司 |
产生ips细胞的方法
|
WO2010022089A2
(en)
|
2008-08-18 |
2010-02-25 |
University Of Maryland, Baltimore |
Derivatives of apf and methods of use
|
JP6133538B2
(ja)
*
|
2008-09-22 |
2017-05-24 |
ベイラー カレッジ オブ メディスンBaylor College Of Medicine |
Cd40およびパターン認識受容体アダプターを誘発することによる免疫応答を生成するための方法および組成物
|
WO2010042481A1
(en)
|
2008-10-06 |
2010-04-15 |
University Of Chicago |
Compositions and methods related to bacterial eap, emp, and/or adsa proteins
|
BRPI0919707B1
(pt)
|
2008-10-14 |
2021-08-17 |
Monsanto Technology Llc |
Cassete de expressão compreendendo uma sequência de nucleotídeos codificadora de ácido graxo dessaturases de hemiselmis spp., produto comercial e método de produção de uma composição alimentar ou de ração
|
US9133475B2
(en)
|
2008-11-26 |
2015-09-15 |
Board Of Trustees Of Michigan State University |
Aphid resistant soybean plants
|
EP2370568B1
(en)
|
2008-12-10 |
2017-07-19 |
Dana-Farber Cancer Institute, Inc. |
Mek mutations conferring resistance to mek inhibitors
|
US8362318B2
(en)
|
2008-12-18 |
2013-01-29 |
Board Of Trustees Of Michigan State University |
Enzyme directed oil biosynthesis in microalgae
|
JP2012515532A
(ja)
|
2009-01-20 |
2012-07-12 |
ラモット アット テル アビブ ユニバーシティ, リミテッド |
Mir−21プロモーター駆動性標的がん治療
|
US20120058523A1
(en)
|
2009-02-17 |
2012-03-08 |
Edenspace Systems Corporation |
Tempering of cellulosic biomass
|
LT3281947T
(lt)
|
2009-04-03 |
2020-05-25 |
The University Of Chicago |
Kompozicijos ir būdai, susiję su baltymo a (spa) variantais
|
WO2011127032A1
(en)
|
2010-04-05 |
2011-10-13 |
University Of Chicago |
Compositions and methods related to protein a (spa) antibodies as an enhancer of immune response
|
ES2568938T3
(es)
|
2009-04-28 |
2016-05-05 |
Vanderbilt University |
Composiciones y procedimientos de tratamiento de trastornos que implican apoptosis de células epiteliales
|
US20120079627A1
(en)
|
2009-05-29 |
2012-03-29 |
Edenspace Systems Corporation |
Plant gene regulatory elements
|
DK3150701T3
(da)
|
2009-06-05 |
2019-01-14 |
Fujifilm Cellular Dynamics Inc |
Reprogrammering af t-celler og hæmatopoietiske celler
|
US20110053803A1
(en)
|
2009-08-26 |
2011-03-03 |
Xin Ge |
Methods for creating antibody libraries
|
HUE038708T2
(hu)
|
2009-09-14 |
2018-11-28 |
Sillajen Biotherapeutics Inc |
Onkolitikus vaccinia vírus kombinációs rákterápia
|
WO2011050271A1
(en)
|
2009-10-23 |
2011-04-28 |
Monsanto Technology Llc |
Methods and compositions for expression of transgenes in plants
|
MX337062B
(es)
|
2009-12-10 |
2016-02-11 |
Ottawa Hospital Res Inst |
Rabdovirus oncolítico.
|
WO2011082253A2
(en)
|
2009-12-30 |
2011-07-07 |
Board Of Trustees Of Michigan State University |
A method to produce acetyldiacylglycerols (ac-tags) by expression ofan acetyltransferase gene isolated from euonymus alatus (burning bush)
|
WO2011100508A2
(en)
|
2010-02-12 |
2011-08-18 |
Arizona Board Of Regents For And On Behalf Of Arizona State University |
Methods and compositions related to glycoprotein-immunoglobulin fusions
|
CN103002894B
(zh)
|
2010-02-25 |
2016-04-06 |
达纳-法伯癌症研究所公司 |
对braf抑制剂具有抗性的braf突变
|
ES2631458T3
(es)
|
2010-03-04 |
2017-08-31 |
Interna Technologies B.V. |
Molécula de ARNmi definida por su fuente y sus usos terapéuticos en el cáncer asociado a la EMT
|
WO2011126976A1
(en)
|
2010-04-07 |
2011-10-13 |
Vanderbilt University |
Reovirus vaccines and methods of use therefor
|
WO2011133512A1
(en)
|
2010-04-19 |
2011-10-27 |
Research Development Foundation |
Rtef-1 variants and uses thereof
|
CA2799614A1
(en)
|
2010-05-19 |
2011-11-24 |
The Samuel Roberts Noble Foundation, Inc. |
Altered leaf morphology and enhanced agronomic properties in plants
|
WO2011146862A1
(en)
|
2010-05-21 |
2011-11-24 |
Bellicum Pharmaceuticals, Inc. |
Methods for inducing selective apoptosis
|
EA028080B1
(ru)
|
2010-06-09 |
2017-10-31 |
Дана-Фарбер Кэнсер Инститьют, Инк. |
Мутация в mek1, придающая устойчивость к ингибиторам raf и mek
|
DK2582794T4
(da)
|
2010-06-15 |
2024-07-22 |
Fujifilm Cellular Dynamics Inc |
Generering af inducerede pluripotente stamceller fra små volumener af perifert blod
|
EP2582793B1
(en)
|
2010-06-15 |
2017-09-06 |
Cellular Dynamics International, Inc. |
A compendium of ready-built stem cell models for interrogation of biological response
|
CA2803298C
(en)
|
2010-07-02 |
2020-07-14 |
The University Of Chicago |
Compositions and methods related to protein a (spa) variants
|
NZ704322A
(en)
|
2010-07-06 |
2016-07-29 |
Interna Technologies Bv |
Mirna and its diagnostic and therapeutic uses in diseases or conditions associated with melanoma, or in diseases or conditions associated with activated braf pathway
|
WO2012006440A2
(en)
|
2010-07-07 |
2012-01-12 |
Cellular Dynamics International, Inc. |
Endothelial cell production by programming
|
US8765470B2
(en)
|
2010-08-04 |
2014-07-01 |
Cellular Dynamics International, Inc. |
Reprogramming immortalized B-cells to induced pluripotent stem cells
|
EP2614074A1
(en)
|
2010-09-09 |
2013-07-17 |
The University of Chicago |
Methods and compositions involving protective staphylococcal antigens
|
CN105457016B
(zh)
|
2010-09-22 |
2022-06-24 |
科罗拉多大学董事会 |
Smad7的治疗应用
|
WO2012061615A1
(en)
|
2010-11-03 |
2012-05-10 |
The Samuel Roberts Noble Foundation, Inc. |
Transcription factors for modification of lignin content in plants
|
US9919047B2
(en)
|
2011-01-04 |
2018-03-20 |
Sillajen, Inc. |
Generation of antibodies to tumor antigens and generation of tumor specific complement dependent cytotoxicity by administration of oncolytic vaccinia virus
|
EP2474617A1
(en)
|
2011-01-11 |
2012-07-11 |
InteRNA Technologies BV |
Mir for treating neo-angiogenesis
|
EP2673299B1
(en)
|
2011-02-07 |
2017-05-10 |
Research Development Foundation |
Engineered immunoglobulin fc polypeptides
|
JP6005666B2
(ja)
|
2011-02-08 |
2016-10-12 |
セルラー ダイナミクス インターナショナル, インコーポレイテッド |
プログラミングによる造血前駆細胞の生産
|
EP3406628A1
(en)
|
2011-04-08 |
2018-11-28 |
Evaxion Biotech ApS |
Proteins and nucleic acids useful in vaccines targeting staphylococcus aureus
|
US8945588B2
(en)
|
2011-05-06 |
2015-02-03 |
The University Of Chicago |
Methods and compositions involving protective staphylococcal antigens, such as EBH polypeptides
|
US8901371B2
(en)
|
2011-05-06 |
2014-12-02 |
The Samuel Roberts Noble Foundation, Inc. |
Compositions and methods for improved plant feedstock
|
WO2012170304A2
(en)
|
2011-06-02 |
2012-12-13 |
The Regents Of The University Of California |
Plants with elevated levels of glucan
|
EP2718427B1
(en)
|
2011-06-08 |
2017-01-11 |
Children's Hospital of Eastern Ontario Research Institute Inc. |
Compositions for glioblastoma treatment
|
WO2013005211A2
(en)
|
2011-07-05 |
2013-01-10 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Boron complexing plant materials and uses thereof cross-reference to related applications
|
EP2732029B1
(en)
|
2011-07-11 |
2019-01-16 |
FUJIFILM Cellular Dynamics, Inc. |
Methods for cell reprogramming and genome engineering
|
JP6317670B2
(ja)
|
2011-08-15 |
2018-04-25 |
ザ・ユニバーシティ・オブ・シカゴThe University Of Chicago |
ブドウ球菌プロテインaに対する抗体に関連した組成物および方法
|
US20130101664A1
(en)
|
2011-08-18 |
2013-04-25 |
Donald W. Kufe |
Muc1 ligand traps for use in treating cancers
|
EP2766388A1
(en)
|
2011-10-12 |
2014-08-20 |
Møller, Niels Iversen |
Peptides derived from campylobacter jejuni and their use in vaccination
|
EP2794881B1
(en)
|
2011-12-22 |
2018-06-27 |
InteRNA Technologies B.V. |
Mirna for treating head and neck cancer
|
EP3805395A1
(en)
|
2012-04-26 |
2021-04-14 |
University Of Chicago |
Staphylococcal coagulase antigens and methods of their use
|
NZ702282A
(en)
|
2012-04-26 |
2016-07-29 |
Univ Chicago |
Compositions and methods related to antibodies that neutralize coagulase activity during staphylococcus aureus disease
|
US9649344B2
(en)
|
2012-07-31 |
2017-05-16 |
The Board Of Regents Of The University Of Texas System |
Methods and compositions for in vivo induction of pancreatic beta cell formation
|
MX350970B
(es)
|
2012-09-24 |
2017-09-26 |
Seminis Vegetable Seeds Inc |
Métodos y composiciones para extender la vida útil en depósito de productos de plantas.
|
WO2014065945A1
(en)
|
2012-10-23 |
2014-05-01 |
The Board Of Regents Of The University Of Texas System |
Antibodies with engineered igg fc domains
|
US10201556B2
(en)
|
2012-11-06 |
2019-02-12 |
Interna Technologies B.V. |
Combination for use in treating diseases or conditions associated with melanoma, or treating diseases or conditions associated with activated B-raf pathway
|
US10253329B2
(en)
|
2013-01-04 |
2019-04-09 |
Board Of Trustees Of Michigan State University |
Sources of aphid resistance in soybean plants
|
WO2014116721A1
(en)
|
2013-01-22 |
2014-07-31 |
The Arizona Board Of Regents For And On Behalf Of Arizona State University |
Geminiviral vector for expression of rituximab
|
MX2015010783A
(es)
|
2013-02-21 |
2016-06-21 |
Children S Hospital Of Eastern Ontario Res Inst Inc |
Composicion de vacuna.
|
US20140242595A1
(en)
|
2013-02-22 |
2014-08-28 |
Cellular Dynamics International, Inc. |
Hepatocyte production via forward programming by combined genetic and chemical engineering
|
WO2014134144A1
(en)
|
2013-02-28 |
2014-09-04 |
The General Hospital Corporation |
Mirna profiling compositions and methods of use
|
US20160010094A1
(en)
|
2013-03-01 |
2016-01-14 |
University Of Pretoria |
Transgenic cell selection
|
US9422352B2
(en)
|
2013-03-08 |
2016-08-23 |
The Regents Of The University Of Colorado, A Body Corporate |
PTD-SMAD7 therapeutics
|
US9434935B2
(en)
|
2013-03-10 |
2016-09-06 |
Bellicum Pharmaceuticals, Inc. |
Modified caspase polypeptides and uses thereof
|
EP2968502B1
(en)
|
2013-03-14 |
2020-08-26 |
Bellicum Pharmaceuticals, Inc. |
Methods for controlling t cell proliferation
|
US9913882B2
(en)
|
2013-06-05 |
2018-03-13 |
Bellicum Pharmaceuticals, Inc. |
Methods for inducing partial apoptosis using caspase polypeptides
|
WO2015035395A1
(en)
|
2013-09-09 |
2015-03-12 |
Figene, Llc |
Gene therapy for the regeneration of chondrocytes or cartilage type cells
|
US10028902B2
(en)
|
2013-11-08 |
2018-07-24 |
Baylor Research Institute |
Nuclear localization of GLP-1 stimulates myocardial regeneration and reverses heart failure
|
EP3065775B1
(en)
|
2013-11-08 |
2020-09-30 |
The Board of Regents of the University of Texas System |
Vh4 antibodies against gray matter neuron and astrocyte
|
EP3077820A1
(en)
|
2013-12-03 |
2016-10-12 |
Evaxion Biotech ApS |
Proteins and nucleic acids useful in vaccines targeting staphylococcus aureus
|
US10392629B2
(en)
|
2014-01-17 |
2019-08-27 |
Board Of Trustees Of Michigan State University |
Increased caloric and nutritional content of plant biomass
|
JP6908381B2
(ja)
|
2014-01-29 |
2021-07-28 |
デイナ ファーバー キャンサー インスティチュート,インコーポレイテッド |
Muc1−c/細胞外ドメイン(muc1−c/ecd)に対する抗体
|
WO2015123527A1
(en)
|
2014-02-14 |
2015-08-20 |
Bellicum Pharmaceuticals, Inc. |
Methods for activating t cells using an inducible chimeric polypeptide
|
EP3105332A4
(en)
|
2014-02-14 |
2018-01-10 |
University of Utah Research Foundation |
Methods and compositions for inhibiting retinopathy of prematurity
|
CA2940765A1
(en)
|
2014-02-25 |
2015-09-03 |
Research Development Foundation |
Sty peptides for inhibition of angiogenesis
|
AR101066A1
(es)
|
2014-03-07 |
2016-11-23 |
Pioneer Hi Bred Int |
Método y disposición para extraer gérmenes de vegetales monocotiledóneos
|
WO2015164228A1
(en)
|
2014-04-21 |
2015-10-29 |
Cellular Dynamics International, Inc. |
Hepatocyte production via forward programming by combined genetic and chemical engineering
|
AR100874A1
(es)
|
2014-06-16 |
2016-11-09 |
Consejo Nac De Investig Científicas Y Técnicas (Conicet) |
Genes quiméricos y proteínas de resistencia oxidativa, y plantas transgénicas que incluyen los mismos
|
WO2016036746A1
(en)
|
2014-09-02 |
2016-03-10 |
Bellicum Pharmaceuticals, Inc. |
Costimulation of chimeric antigen receptors by myd88 and cd40 polypeptides
|
AU2015315671A1
(en)
|
2014-09-11 |
2017-02-02 |
Marrone Bio Innovations, Inc |
Chromobacterium subtsugae genome.
|
JP6718444B2
(ja)
|
2014-11-03 |
2020-07-08 |
アカデミッシュ ザイケンホイス レイデン (エイチ.オー.ディー.エヌ. エルユーエムシー) |
Bob1に対して指向されるT細胞レセプターおよびその使用
|
UA124449C2
(uk)
|
2014-11-12 |
2021-09-22 |
Нмк, Інк. |
Трансгенна рослина з модифікованою редокс-залежною модуляцією пігментів фотосинтетичних антенних комплексів та спосіб її одержання
|
WO2016075305A2
(en)
|
2014-11-13 |
2016-05-19 |
Evaxion Biotech Aps |
Peptides derived from acinetobacter baumannii and their use in vaccination
|
EP3234145B1
(en)
|
2014-12-15 |
2019-06-05 |
Bellicum Pharmaceuticals, Inc. |
Methods for controlled activation or elimination of therapeutic cells
|
EP3485907B1
(en)
|
2015-01-12 |
2023-06-28 |
Evaxion Biotech ApS |
Treatment and prophylaxis of k. pneumoniae infection
|
US20180002656A1
(en)
|
2015-01-28 |
2018-01-04 |
Sabic Global Technologies B.V. |
Methods and compositions for high-efficiency production of biofuel and/or biomass
|
US10457737B2
(en)
|
2015-02-09 |
2019-10-29 |
Research Development Foundation |
Engineered immunoglobulin Fc polypeptides displaying improved complement activation
|
EP3259346B1
(en)
|
2015-02-20 |
2024-08-07 |
Baylor College of Medicine |
P63 inactivation for the treatment of heart failure
|
ES2933030T3
(es)
|
2015-03-10 |
2023-01-31 |
Academisch Ziekenhuis Leiden H O D N Leids Univ Medisch Centrum |
Receptores de células T dirigidos contra el antígeno de melanoma expresado preferencialmente y usos de los mismos
|
US20180201656A1
(en)
|
2015-07-04 |
2018-07-19 |
Evaxion Biotech Aps |
Proteins and nucleic acids useful in vaccines targeting Pseudomonas Aeruginosa
|
US10526408B2
(en)
|
2015-08-28 |
2020-01-07 |
Research Development Foundation |
Engineered antibody FC variants
|
US10947502B2
(en)
|
2015-10-20 |
2021-03-16 |
FUJIFILM Cellular Dynamics, Inc. |
Methods for directed differentiation of pluripotent stem cells to immune cells
|
CN108463548B
(zh)
|
2015-10-30 |
2023-04-18 |
加利福尼亚大学董事会 |
由干细胞产生t细胞的方法及使用所述t细胞的免疫治疗方法
|
ES2892972T3
(es)
|
2015-11-02 |
2022-02-07 |
Univ Texas |
Métodos de activación de CD40 y bloqueo de punto de control inmunitario
|
CA3004530A1
(en)
|
2015-11-07 |
2017-05-11 |
Multivir Inc. |
Methods and compositions comprising tumor suppressor gene therapy and immune checkpoint blockade for the treatment of cancer
|
RS65666B1
(sr)
|
2015-11-09 |
2024-07-31 |
Childrens Hospital Philadelphia |
Glipikan 2 kao tumor marker i terapijski cilj
|
WO2017144523A1
(en)
|
2016-02-22 |
2017-08-31 |
Evaxion Biotech Aps |
Proteins and nucleic acids useful in vaccines targeting staphylococcus aureus
|
EP3436049B1
(en)
|
2016-03-31 |
2022-01-12 |
Baylor Research Institute |
Angiopoietin-like protein 8 (angptl8)
|
WO2017216384A1
(en)
|
2016-06-17 |
2017-12-21 |
Evaxion Biotech Aps |
Vaccination targeting ichthyophthirius multifiliis
|
WO2017220787A1
(en)
|
2016-06-24 |
2017-12-28 |
Evaxion Biotech Aps |
Vaccines against aearomonas salmonicida infection
|
US20180030478A1
(en)
|
2016-07-01 |
2018-02-01 |
Research Development Foundation |
Elimination of proliferating cells from stem cell-derived grafts
|
EP3889167A1
(en)
|
2016-07-22 |
2021-10-06 |
Evaxion Biotech ApS |
Chimeric proteins for inducing immunity towards infection with s. aureus
|
WO2018035429A1
(en)
|
2016-08-18 |
2018-02-22 |
Wisconsin Alumni Research Foundation |
Peptides that inhibit syndecan-1 activation of vla-4 and igf-1r
|
CA3034739A1
(en)
|
2016-08-22 |
2018-03-01 |
Biolumic Limited |
System, device and methods of seed treatment
|
CN109963590B
(zh)
|
2016-09-02 |
2024-03-15 |
加利福尼亚大学董事会 |
涉及白介素-6受体α结合单链可变片段的方法和组合物
|
MX2019003689A
(es)
|
2016-10-05 |
2019-08-22 |
Fujifilm Cellular Dynamics Inc |
Metodos para diferenciacion dirigida de citoblastos pluripotentes a células inminitarias homocigotas de antígenos leucocitarios humanos.
|
CN110050061A
(zh)
|
2016-10-05 |
2019-07-23 |
富士胶片细胞动力公司 |
从具有MeCP2破坏的诱导多能干细胞生成成熟谱系
|
RU2646108C1
(ru)
*
|
2016-12-07 |
2018-03-01 |
Федеральное государственное бюджетное учреждение науки Институт биологии развития им. Н.К. Кольцова РАН |
Способ получения трансгенных растений пшеницы с использованием биобаллистики
|
CA3046961A1
(en)
|
2016-12-12 |
2018-06-21 |
Multivir Inc. |
Methods and compositions comprising viral gene therapy and an immune checkpoint inhibitor for treatment and prevention of cancer and infectious diseases
|
US11718648B2
(en)
|
2017-01-05 |
2023-08-08 |
Evaxion Biotech A/S |
Vaccines targeting Pseudomonas aeruginosa
|
US11180770B2
(en)
|
2017-03-07 |
2021-11-23 |
BASF Agricultural Solutions Seed US LLC |
HPPD variants and methods of use
|
US11371056B2
(en)
|
2017-03-07 |
2022-06-28 |
BASF Agricultural Solutions Seed US LLC |
HPPD variants and methods of use
|
US20200123501A1
(en)
|
2017-04-18 |
2020-04-23 |
FUJIFILM Cellular Dynamics, Inc. |
Antigen-specific immune effector cells
|
US20210147507A1
(en)
|
2017-05-09 |
2021-05-20 |
Bellicum Pharmaceuticals, Inc. |
Methods to augment or alter signal transduction
|
WO2019038594A2
(en)
|
2017-08-21 |
2019-02-28 |
Biolumic Limited |
TRANSGENIC PLANTS WITH HIGH GROWTH AND HIGH RUSTICITY
|
US11497762B2
(en)
|
2017-11-03 |
2022-11-15 |
Interna Technologies B.V. |
MiRNA molecule, equivalent, antagomir, or source thereof for treating and/or diagnosing a condition and/or a disease associated with neuronal deficiency or for neuronal (re)generation
|
US11612618B2
(en)
|
2017-11-14 |
2023-03-28 |
Henry Ford Health System |
Compositions for use in the treatment and prevention of cardiovascular disorders resulting from cerebrovascular injury
|
WO2019134049A1
(en)
|
2018-01-05 |
2019-07-11 |
Bell John C |
Modified vaccinia vectors
|
WO2019145399A1
(en)
|
2018-01-24 |
2019-08-01 |
Evaxion Biotech Aps |
Vaccines for prophylaxis of s. aureus infections
|
EP3768698A4
(en)
|
2018-03-19 |
2022-03-30 |
MultiVir Inc. |
METHODS AND COMPOSITIONS COMPRISING TUMOR SUPPRESSIVE GENE THERAPY AND CD122/CD132 AGONISTS FOR THE TREATMENT OF CANCER
|
CN112105731B
(zh)
|
2018-03-30 |
2024-08-30 |
日内瓦大学 |
微小rna表达构建体及其用途
|
WO2020069313A2
(en)
|
2018-09-28 |
2020-04-02 |
Henry Ford Health System |
Use of extracellular vesicles in combination with tissue plasminogen activator and/or thrombectomy to treat stroke
|
US20220111031A1
(en)
|
2018-10-22 |
2022-04-14 |
Evaxion Biotech Aps |
Vaccines targeting M. catharrhalis
|
WO2020171889A1
(en)
|
2019-02-19 |
2020-08-27 |
University Of Rochester |
Blocking lipid accumulation or inflammation in thyroid eye disease
|
WO2020174044A1
(en)
|
2019-02-27 |
2020-09-03 |
Evaxion Biotech Aps |
Vaccines targeting h. influenzae
|
WO2020212756A2
(en)
|
2019-04-18 |
2020-10-22 |
Genkin Dmitry Dmitrievich |
Reprogramming of polymorphonuclear leukocytes
|
CN114555807A
(zh)
|
2019-07-19 |
2022-05-27 |
费城儿童医院 |
包含磷脂酰肌醇蛋白聚糖2结合结构域的嵌合抗原受体
|
CN115175680A
(zh)
|
2019-10-18 |
2022-10-11 |
加利福尼亚大学董事会 |
Plxdc激活剂及其用于治疗血管病症的用途
|
WO2021113644A1
(en)
|
2019-12-05 |
2021-06-10 |
Multivir Inc. |
Combinations comprising a cd8+ t cell enhancer, an immune checkpoint inhibitor and radiotherapy for targeted and abscopal effects for the treatment of cancer
|
US20230050225A1
(en)
|
2020-01-06 |
2023-02-16 |
Evaxion Biotech A/S |
Vaccines targeting Neisseria gonorrhoeae
|
WO2021240240A1
(en)
|
2020-05-27 |
2021-12-02 |
Antion Biosciences Sa |
Adapter molecules to re-direct car t cells to an antigen of interest
|
JP2023536210A
(ja)
|
2020-05-29 |
2023-08-24 |
フジフィルム セルラー ダイナミクス,インコーポレイテッド |
網膜色素上皮及び光受容体の二重層、並びにその使用
|
JP2023528377A
(ja)
|
2020-05-29 |
2023-07-04 |
フジフィルム セルラー ダイナミクス,インコーポレイテッド |
網膜色素上皮及び光受容体の二重細胞凝集体、並びにその使用方法
|
WO2022053130A1
(en)
|
2020-09-09 |
2022-03-17 |
Sid Alex Group, S.R.O. |
Antago-mir-155 for treatment of v-src, c-src-tyrosine kinase-induced cancers
|
WO2022133169A1
(en)
|
2020-12-18 |
2022-06-23 |
Century Therapeutics, Inc. |
Chimeric antigen receptor systems with adaptable receptor specificity
|
US20240123004A1
(en)
|
2021-02-09 |
2024-04-18 |
University Of Houston System |
Oncolytic virus for systemic delivery and enhanced anti-tumor activities
|
EP4294445A1
(en)
|
2021-02-19 |
2023-12-27 |
Pfizer Inc. |
Methods of protecting rna
|
AU2022255504A1
(en)
|
2021-04-08 |
2023-11-23 |
Janssen Biotech, Inc. |
Materials and methods for enhanced stem-cell like memory t cell engineering
|
CA3216719A1
(en)
|
2021-05-03 |
2022-11-10 |
Astellas Institute For Regenerative Medicine |
Methods of generating mature corneal endothelial cells
|
JP2024518409A
(ja)
|
2021-05-07 |
2024-05-01 |
アステラス インスティテュート フォー リジェネラティブ メディシン |
成熟肝細胞を作製する方法
|
AU2022280051A1
(en)
|
2021-05-26 |
2023-11-23 |
FUJIFILM Cellular Dynamics, Inc. |
Methods to prevent rapid silencing of genes in pluripotent stem cells
|
AU2022307747A1
(en)
|
2021-07-05 |
2024-01-25 |
Evaxion Biotech A/S |
Vaccines targeting neisseria gonorrhoeae
|
WO2023081813A1
(en)
|
2021-11-05 |
2023-05-11 |
St. Jude Children's Research Hospital, Inc. |
Zip cytokine receptors
|
WO2023081894A2
(en)
|
2021-11-08 |
2023-05-11 |
St. Jude Children's Research Hospital, Inc. |
Pre-effector car-t cell gene signatures
|
WO2023089556A1
(en)
|
2021-11-22 |
2023-05-25 |
Pfizer Inc. |
Reducing risk of antigen mimicry in immunogenic medicaments
|
GB2614309A
(en)
|
2021-12-24 |
2023-07-05 |
Stratosvir Ltd |
Improved vaccinia virus vectors
|
WO2023144779A1
(en)
|
2022-01-28 |
2023-08-03 |
Pfizer Inc. |
Coronavirus antigen variants
|
CA3242289A1
(en)
|
2022-03-16 |
2023-09-21 |
University Of Houston System |
Persistent hsv gene delivery system
|
WO2023213393A1
(en)
|
2022-05-04 |
2023-11-09 |
Evaxion Biotech A/S |
Staphylococcal protein variants and truncates
|
GB202206507D0
(en)
|
2022-05-04 |
2022-06-15 |
Antion Biosciences Sa |
Expression construct
|
WO2023240109A1
(en)
|
2022-06-07 |
2023-12-14 |
Regeneron Pharmaceuticals, Inc. |
Multispecific molecules for modulating t-cell activity, and uses thereof
|
WO2023240182A1
(en)
|
2022-06-08 |
2023-12-14 |
St. Jude Children's Research Hospital, Inc. |
Disruption of kdm4a in t cells to enhance immunotherapy
|
US20240010742A1
(en)
|
2022-06-10 |
2024-01-11 |
Research Development Foundation |
Engineered fcriib selective igg1 fc variants and uses thereof
|
US20240003871A1
(en)
|
2022-06-29 |
2024-01-04 |
FUJIFILM Cellular Dynamics, Inc. |
Ipsc-derived astrocytes and methods of use thereof
|
WO2024059787A1
(en)
|
2022-09-16 |
2024-03-21 |
St. Jude Children's Research Hospital, Inc. |
Disruption of asxl1 in t cells to enhance immunotherapy
|
WO2024130212A1
(en)
|
2022-12-16 |
2024-06-20 |
Turnstone Biologics Corp. |
Recombinant vaccinia virus encoding one or more natural killer cell and t lymphocyte inhibitors
|